Cargando…
A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
One hundred and seventy-five children with Stage 3 or 4 neuroblastoma who had obtained a good response to conventional therapy were randomly allocated to 13-Cis retinoic acid at a dose of 0.75 mg/kg/day or placebo for up to 4 years. Toxicity was mild but no advantage in event-free survival was shown...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2000
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363577/ https://www.ncbi.nlm.nih.gov/pubmed/11027423 http://dx.doi.org/10.1054/bjoc.2000.1425 |